JOSEPH JAFFKE: Open Payments
NPI 1467057521 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,738 in 138 payments from 20 companies in 2025. Trend: 2023 $2,933 · 2024 $3,222 · 2025 $2,738
Food & beverage: $2,738
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $337 |
| ABBVIE INC. | 22 | $284 |
| Vanda Pharmaceuticals Inc. | 13 | $277 |
| E.R. Squibb & Sons, L.L.C. | 10 | $243 |
| Supernus Pharmaceuticals, Inc. | 9 | $205 |
| Lundbeck LLC | 9 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $180 |
| Almatica Pharma LLC | 7 | $154 |
| Otsuka America Pharmaceutical, Inc. | 7 | $138 |
| Tris Pharma Inc | 6 | $115 |
Products named: Auvelity, REXULTI, VRAYLAR, HETLIOZ, COBENFY, Qelbree, CAPLYTA, LOREEV XR.
Industry payments across SC — which companies pay providers there.
